The Effect of Antiviral Therapy With Pegylated Interferon-alpha for Chronic Hepatitis C and B on Auditory Disability: A Prospective Study.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis B; Hepatitis C
- Focus Adverse reactions
- 20 Jul 2016 Status changed from recruiting to completed.
- 18 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 01 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.